Navigation Links
BioLineRx Presents Phase I Clinical Data of BL-1020 at Upcoming,Clinical Conferences

JERUSALEM--(BUSINESS WIRE)--May 17, 2007 - BioLineRx Ltd. (TASE: BLRX), Israel's leading drug development company, announced today that abstracts containing data from its successfully completed phase I clinical trails of BL-1020, first in class GABA-enhanced antipsychotic for the treatment of schizophrenia, have been accepted for poster presentations at three leading scientific conferences. The data will be presented at the following conferences:

-- Society of Biological Psychiatry Annual Convention, May 17-19 (San Diego)

-- American Psychiatric Association Annual Meeting, May 19-24 (San Diego)

-- New Clinical Drug Evaluation Unit Annual (NCDEU) Meeting, June 11-14 (Boca Raton)

The abstract which has been selected for these poster presentations describes the results of a Phase I, randomized, placebo-controlled double blinded, single dose-escalation study to evaluate the safety and determine the pharmacokinetic profile of BL-1020, first in class GABA-enhanced antipsychotic for the treatment of schizophrenia.

"We are very pleased that these important data regarding the Phase I trials of BL-1020 are being presented at these three major psychiatric conferences. The Phase I studies support our product profile of a highly efficacious antipsychotic devoid of extrapyramidal symptoms or metabolic side effects," commented Morris Laster, chief executive officer of BioLineRx. "We continue to believe that the compound holds great promise for the treatment of schizophrenia, which currently poses an intractable medical problem for physicians and patients. We very much look forward to the initiation of the Phase II trial in the second quarter of 2007."

About BL-1020

BL-1020 is an orally available GABA enhanced antipsychotic clinical candidate for the treatment of schizophrenia. Data from preclinical and phase I studies demonstrated that the compound may retain the efficacy of currently
'"/>




Page: 1 2 3

Related medicine technology :

1. BioLineRx Presents Data From Successful Phase I Trial for BL-1020 in Schizophrenia at American Psychiatric Association Conference
2. BioLineRx Presents Data on BL-1040 at Cardiovascular Revascularization Therapies Conference Demonstrating Potential to Reduce Deterioration of Infarcted Heart Tissue and Maintain Functionality
3. Inspiration Biopharmaceuticals Presents Data From Hemophilia Program at International Society On Thrombosis and Haemostasis (ISTH) Annual Meeting
4. European Society for Medical Oncology (ESMO) Presents Data from the Clinical Trial of MediGenes Cancer-Killing Virus in Press Conference
5. Cytogen Presents Phase 1 Data Showing Promising Antitumor Activity and Safety Profile of Quadramet at International Myeloma Workshop
6. SemBioSys Presents Positive Insulin Data at the American Diabetes Association Conference
7. Tranzyme Pharma Presents Initial Phase IIa Data for its Novel Ghrelin Agonist, TZP-101, in Patients with Diabetic Gastroparesis
8. Novagali Pharma Presents at AACO the Results of its Pivotal Phase III Clinical Trial of Vekacia in Children Suffering From Vernal Keratoconjunctivitis
9. BioLife Solutions Presents Data on CryoStor at International Society for Cellular Therapy Annual Meeting
10. Genaera Presents Preclinical Data on Trodusquemine (MSI-1436) for the Treatment of Obesity at the American Diabetes Association 67th Scientific Session
11. Elixir Pharmaceuticals Presents Preclinical Data Highlighting Its Ghrelin Antagonist Program at the American Diabetes Associations Annual Meeting
Post Your Comments:
(Date:5/23/2013)... 2013 3SBio Inc. (NASDAQ: ... China -based biotechnology company focused ... announced today that, at an extraordinary general meeting ... in favor of the proposal to authorize and ... merger dated February 8, 2013, among Decade Sunshine ...
(Date:5/23/2013)... May 23, 2013 Neurocrine Biosciences, Inc. (Nasdaq: ... , President and Chief Executive Officer of Neurocrine Biosciences, ... Annual dbAccess Health Care Conference in Boston.   ... 11:20 a.m. Eastern Time / 8:20 a.m. Pacific Time.  The ... Company,s website at http://www.neurocrine.com . If ...
(Date:5/23/2013)... EDGE, N.J. , May 23, 2013 ... a commercial stage medical device company that develops and ... successful completion of its rights offering.  In addition, the ... March 2011 warrants expired on May 17, 2013. ... of $3.0 million from the rights offering.   A portion ...
Breaking Medicine Technology:3SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 23SBio Inc. Announces Shareholders' Approval of the Amended Merger Agreement 3Nephros Announces Completion of Rights Offering 2Nephros Announces Completion of Rights Offering 3Nephros Announces Completion of Rights Offering 4
... Hanger Orthopedic Group, Inc. (NYSE: HGR ) announced ... the quarter ended March 31, 2011, on Thursday, April 28, 2011. ... the results for the quarter ended March 31, 2011 on Wednesday, ... call to discuss these results is scheduled to begin at 9:00 ...
... LUBBOCK, Texas, April 8, 2011 The MED Group, ... a leading group purchasing and business solutions company focused ... the creation of The MED Group National Orthotics and ... joined The MED Group and will be leading the ...
Cached Medicine Technology:Hanger Orthopedic Group, Inc. Announces First Quarter 2011 Earnings Release Conference Call 2The MED Group Launches the New National Orthotics & Prosthetics Network 2
(Date:5/24/2013)... May 24, 2013 Today, Zane ... Indiana Health Insurance Exchange . Zane Benefits, ... employer sponsored health benefits, is the leader in ... reimbursement arrangements . , According to Zane Benefits’ ... Affordable Care Act (ACA), health insurance coverage for ...
(Date:5/24/2013)... 2013 This week is National EMS ... efforts to provide the best emergency care and to ... week is also to educate the public that all ... Citizens are the first link, and a very important ... CPR after a cardiac arrest can triple a victim’s ...
(Date:5/24/2013)... Reporter , , FRIDAY, May 24 (HealthDay News) -- As ... it was a physical challenge in her childhood that ... "I was an 11-year-old girl with my heart ... by my orthopedic surgeon," said Lewis, who has become ... the American Academy of Orthopaedic Surgeons so she can ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 Western University ... its status of “Full Accreditation” for the next seven ... on Education (COE). , “This is a magnificent achievement, ... hard work and student outcomes,” said College of Veterinary ... express my appreciation to the faculty, staff, preceptors, and ...
(Date:5/24/2013)... (PRWEB) May 24, 2013 KC and Monica ... Title Sponsors for FreeRide836. Their oldest sons, Kyle and Austin ... Tracey Russell family and several professional kiteboarders. , KC Craichy ... project. "This has miraculously come together such that virtually everyone ... to participate." , 20 kite boarders will meet at Matheson ...
Breaking Medicine News(10 mins):Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 2Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 3Health News:Zane Benefits Publishes New Information on the Indiana Health Insurance Exchange 4Health News:Acadian Medics Reunite with Miracle Baby 2Health News:Top-Ranked Golfer Beats Scoliosis 2Health News:Top-Ranked Golfer Beats Scoliosis 3Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 2Health News:FreeRide836 Sponsor Living Fuel, The Leader in Superfood Nutrition, Announces Kiteboard Launch For This Sunday To Raise Money For Orphans In Africa 3
... Software Platform-HealthRules(R)-Poised to ... Change the Rules for Healthcare Payors, BURLINGTON, ... claims and benefit administration, business,intelligence and portal software products ... $13 million investment commitment from,Psilos Group, a leading healthcare ...
... 22 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin Board: CHBT) ... the manufacture,research, development, marketing and distribution of probiotics ... centers in the,first quarter of 2008. Currently, the ... six major cities in China., "We are ...
... Just in time for Earth,Day, Bragada(R) Luxury ... new line of high-end mattresses that demonstrate Bragada,s ... of its customers., While all Bragada Luxury ... -- a renewable resource -- the company,s,new PUR ...
... Services, a,division of Omnicom Group Inc. (NYSE: OMC ... agencies Cline Davis Mann, Corbett and,Flashpoint of Med Ad ... Annual,Manny Awards., Cline Davis Mann won Agency of ... revenue of more than $50 million. Corbett dominated,the competition ...
... MAUI, Hawaii, April 22 Bioponic,Phytoceuticals, Inc. ... today announced that Dr. Barbara Anne Nabrit-Stephens, ... Advisory Board. Dr.,Nabrit-Stephens is a board-certified pediatrician ... As a scientific advisor, Dr. Nabrit-Stephens will,help ...
... TUESDAY, April 22 (HealthDay News) -- Skin lesions ... likely than smaller lesions to be melanoma skin ... supports the current widespread use of diameter guidelines ... "ABCDE" screening method is based on five features ...
Cached Medicine News:Health News:HealthEdge Receives $13 Million Investment Commitment to Fund Significant Growth 2Health News:China-Biotics, Inc. Expands Retail Network to 60 Shining Retail Centers 2Health News:China-Biotics, Inc. Expands Retail Network to 60 Shining Retail Centers 3Health News:Bragada(R) Luxury Mattress, Inc. Goes Green 2Health News:Omnicom's Diversified Agency Services Healthcare Agencies Top Med Ad News' Manny Awards 2Health News:Bioponic Phytoceuticals Appoints Renowned Physician Dr. Barbara Nabrit-Stephens to Scientific Advisory Board 2Health News:Bioponic Phytoceuticals Appoints Renowned Physician Dr. Barbara Nabrit-Stephens to Scientific Advisory Board 3Health News:Larger Skin Lesions More Likely to Be Melanoma 2
Rev. Angled 9.5 overall length 4.5 handle 240 mm....
Temporary...
Malis Needle Holders, bayonet, titanium. Working distance 2 1/2" (63 mm). Straight tip with width 0.6 mm....
Clinical micro clamps by Acland. Matte finish. It provides impressive security in use, both against slippage and against leakage due to controlled closing force and working grip surface....
Medicine Products: